-
Je něco špatně v tomto záznamu ?
Lack of PRKD2 and PRKD3 kinase domain somatic mutations in PRKD1 wild-type classic polymorphous low-grade adenocarcinomas of the salivary gland
S. Piscuoglio, N. Fusco, CK. Ng, LG. Martelotto, A. da Cruz Paula, N. Katabi, BP. Rubin, A. Skálová, I. Weinreb, B. Weigelt, JS. Reis-Filho,
Jazyk angličtina Země Velká Británie
Typ dokumentu časopisecké články
PubMed
26426580
DOI
10.1111/his.12883
Knihovny.cz E-zdroje
- MeSH
- adenokarcinom diagnóza enzymologie genetika patologie MeSH
- dospělí MeSH
- genotyp MeSH
- genová přestavba MeSH
- lidé středního věku MeSH
- lidé MeSH
- mikrodisekce MeSH
- mutace MeSH
- nádory slinných žláz diagnóza enzymologie genetika patologie MeSH
- proteinkinasa C genetika MeSH
- proteinové domény MeSH
- sekvence aminokyselin MeSH
- sekvenční analýza DNA MeSH
- sekvenční seřazení MeSH
- senioři MeSH
- slinné žlázy patologie MeSH
- Check Tag
- dospělí MeSH
- lidé středního věku MeSH
- lidé MeSH
- mužské pohlaví MeSH
- senioři MeSH
- ženské pohlaví MeSH
- Publikační typ
- časopisecké články MeSH
AIMS: Polymorphous low-grade adenocarcinoma (PLGA) is the second most common intra-oral salivary gland malignancy. The vast majority of PLGAs harbour a PRKD1 E710D hot-spot somatic mutation or somatic rearrangements of PRKD1, PRKD2 or PRKD3. Given the kinase domain homology among PRKD1, PRKD2 and PRKD3, we sought to define whether PLGAs lacking PRKD1 somatic mutations or PRKD gene family rearrangements would be driven by somatic mutations affecting the kinase domains of PRKD2 or PRKD3. METHODS AND RESULTS: DNA was extracted from eight microdissected PLGAs lacking PRKD1 somatic mutations or PRKD gene family rearrangements. Samples were thoroughly centrally reviewed, microdissected and subjected to Sanger sequencing of the kinase domains of the PRKD2 and PRKD3 genes. None of the PLGAs lacking PRKD1 somatic mutations or PRKD gene family rearrangements harboured somatic mutations in the kinase domains of the PRKD2 or PRKD3 genes. CONCLUSION: PLGAs lacking PRKD1 somatic mutations or PRKD gene family rearrangements are unlikely to harbour somatic mutations in the kinase domains of PRKD2 or PRKD3. Further studies are warranted to define the driver genetic events in this subgroup of PLGAs.
Department of Pathology Medical Faculty of Charles University Plzen Czech Republic
Department of Pathology Memorial Sloan Kettering Cancer Center New York NY USA
Department of Pathology University Health Network Toronto Ontario Canada
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc18017394
- 003
- CZ-PrNML
- 005
- 20180516140248.0
- 007
- ta
- 008
- 180515s2016 xxk f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1111/his.12883 $2 doi
- 035 __
- $a (PubMed)26426580
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxk
- 100 1_
- $a Piscuoglio, Salvatore $u Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
- 245 10
- $a Lack of PRKD2 and PRKD3 kinase domain somatic mutations in PRKD1 wild-type classic polymorphous low-grade adenocarcinomas of the salivary gland / $c S. Piscuoglio, N. Fusco, CK. Ng, LG. Martelotto, A. da Cruz Paula, N. Katabi, BP. Rubin, A. Skálová, I. Weinreb, B. Weigelt, JS. Reis-Filho,
- 520 9_
- $a AIMS: Polymorphous low-grade adenocarcinoma (PLGA) is the second most common intra-oral salivary gland malignancy. The vast majority of PLGAs harbour a PRKD1 E710D hot-spot somatic mutation or somatic rearrangements of PRKD1, PRKD2 or PRKD3. Given the kinase domain homology among PRKD1, PRKD2 and PRKD3, we sought to define whether PLGAs lacking PRKD1 somatic mutations or PRKD gene family rearrangements would be driven by somatic mutations affecting the kinase domains of PRKD2 or PRKD3. METHODS AND RESULTS: DNA was extracted from eight microdissected PLGAs lacking PRKD1 somatic mutations or PRKD gene family rearrangements. Samples were thoroughly centrally reviewed, microdissected and subjected to Sanger sequencing of the kinase domains of the PRKD2 and PRKD3 genes. None of the PLGAs lacking PRKD1 somatic mutations or PRKD gene family rearrangements harboured somatic mutations in the kinase domains of the PRKD2 or PRKD3 genes. CONCLUSION: PLGAs lacking PRKD1 somatic mutations or PRKD gene family rearrangements are unlikely to harbour somatic mutations in the kinase domains of PRKD2 or PRKD3. Further studies are warranted to define the driver genetic events in this subgroup of PLGAs.
- 650 _2
- $a adenokarcinom $x diagnóza $x enzymologie $x genetika $x patologie $7 D000230
- 650 _2
- $a dospělí $7 D000328
- 650 _2
- $a senioři $7 D000368
- 650 _2
- $a sekvence aminokyselin $7 D000595
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 _2
- $a genová přestavba $7 D015321
- 650 _2
- $a genotyp $7 D005838
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 _2
- $a mikrodisekce $7 D042282
- 650 _2
- $a lidé středního věku $7 D008875
- 650 _2
- $a mutace $7 D009154
- 650 _2
- $a proteinové domény $7 D000072417
- 650 _2
- $a proteinkinasa C $x genetika $7 D011493
- 650 _2
- $a nádory slinných žláz $x diagnóza $x enzymologie $x genetika $x patologie $7 D012468
- 650 _2
- $a slinné žlázy $x patologie $7 D012469
- 650 _2
- $a sekvenční seřazení $7 D016415
- 650 _2
- $a sekvenční analýza DNA $7 D017422
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Fusco, Nicola $u Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY, USA. Division of Pathology, Fondazione IRCCS Ca' Granda - Ospedale Maggiore Policlinico, Milan, Italy.
- 700 1_
- $a Ng, Charlotte K Y $u Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
- 700 1_
- $a Martelotto, Luciano G $u Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
- 700 1_
- $a da Cruz Paula, Arnaud $u Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY, USA. Instituto Português de Oncologia, Oporto, Portugal.
- 700 1_
- $a Katabi, Nora $u Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
- 700 1_
- $a Rubin, Brian P $u Department of Pathology, Robert J Tomsich Pathology and Laboratory Medicine Institute, Cleveland Clinic, Cleveland, OH, USA.
- 700 1_
- $a Skálová, Alena $u Department of Pathology, Medical Faculty of Charles University, Plzen, Czech Republic.
- 700 1_
- $a Weinreb, Ilan $u Department of Pathology, University Health Network, Toronto, Ontario, Canada.
- 700 1_
- $a Weigelt, Britta $u Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
- 700 1_
- $a Reis-Filho, Jorge S $u Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
- 773 0_
- $w MED00002043 $t Histopathology $x 1365-2559 $g Roč. 68, č. 7 (2016), s. 1055-62
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/26426580 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20180515 $b ABA008
- 991 __
- $a 20180516140424 $b ABA008
- 999 __
- $a ok $b bmc $g 1301018 $s 1014234
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2016 $b 68 $c 7 $d 1055-62 $e 20160104 $i 1365-2559 $m Histopathology $n Histopathology $x MED00002043
- LZP __
- $a Pubmed-20180515